| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	Prioritized Regulatory Review Process in the U.S. Follows Japan PMDA Approval in SeptemberWARSAW, Ind., Oct. 28, 2025 /PRNewswi...
 
																	Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and maintains $101 price t...
 
																	
 
																	BTIG analyst Ryan Zimmerman maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $118 to ...
 
																	Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings (NYSE:ZBH) with a In-Line and lowers the price targe...
 
																	
 
																	iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on th...
 
																	Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $115 to $118.